Michael P. Stansky - 14 May 2026 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
15 May 2026, 16:39:01 UTC
Prior SEC filing
23 Feb 2026
Next SEC filing
18 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Mary Szela, Attorney-in-Fact

Key filing fact

Michael P. Stansky filed Form 4 for TriSalus Life Sciences, Inc. (TLSI) on 15 May 2026.

Key facts

  • This page summarizes Michael P. Stansky's Form 4 filing for TriSalus Life Sciences, Inc. (TLSI).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 15 May 2026, 16:39.

Change

  • Previous filing in this sequence was filed on 23 Feb 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001424204 Primary reporting owner

Stansky Michael P

Relationship
Director
Address
6272 W. 91ST AVENUE, WESTMINSTER
Signature
/s/ Mary Szela, Attorney-in-Fact
Signature date
15 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TLSI transaction

Common Stock

Award

Transaction value
Shares
+23,501
Change %
+3%
Price
$0.000000*
Shares after
810,633
Date
14 May 2026
Ownership
Direct
Footnotes
F1
TLSI transaction

Common Stock

Award

Transaction value
Shares
+20,089
Change %
+2.5%
Price
$0.000000*
Shares after
830,722
Date
14 May 2026
Ownership
Direct
Footnotes
F2
TLSI holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
199,698
Date
14 May 2026
Ownership
By Skyview Investments LLC
Footnotes
F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TLSI transaction Derivative

Director Stock Option (right to buy)

Award

Transaction value
Shares
+47,003
Change %
+51%
Price
$0.000000*
Shares after
139,540
Date
14 May 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
47,003
Exercise price
$2.52
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU award shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer.

Footnote F2

Represents grant of restricted stock units (the "Retainer RSU Award") payable solely in common stock of the Issuer. The Reporting Person elected to receive the Retainer RSU Award in lieu of 2026 board service retainer cash fees provided for under the Issuer's Non-Employee Director Compensation Policy. The shares subject to the Retainer RSU Award shall vest quarterly in equal one-third installments through the remainder of 2026, subject to the Reporting Person's continued service with the Issuer.

Footnote F3

The securities reported herein are owned by Skyview Investments LLC. Mr. Stansky serves as managing member of Skyview Investments LLC (and in such capacity may be deemed to beneficially own the securities reported herein). Voting and dispositive power over the securities owned by Skyview Investments LLC is exercised in his capacity as managing member.

Footnote F4

The shares subject to the option shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .